Here are 18 key notes on spine and orthopedic device companies.
Bacterin extended its contract with Novation.
The United States Department of Justice extended the deferred prosecution agreement for Biomet related to Foreign Corrupt Practices Act violations in October 2013, before Zimmer announced it would acquire the company.
Blue Belt Technologies announced that the first Navio-assisted surgery was successfully performed in Australia.
Since combining with Covidien, the new Medtronic Plc is undervalued.
Globus Medical's price target was recently updated to $28 by Oppenheimer.
Greatbatch reported a loss of 48,580 shares or 8.5 percent in the short interest.
Cardinal Health recently purchased Johnson & Johnson's cardiovascular technologies business for $1.9 billion.
K2M reported revenue growth in 2014 — revenue was up 15.7 percent in the fourth quarter and 18.5 percent in the full year, reaching $186.7 million in 2014.
Medtronic CEO Omar Ishrak sold 20,000 shares of the company's stock.
NuVasive COO Patrick Miles sold 7,920 shares of the stock in a recent transaction.
OsteoRemedies named Eric A. Stookey COO.
Silver Bullet Therapeutics received CE Mark approval for the commercial sale of its OrthoFuzIon Cannulated Bone Screw System.
The U.S. Food and Drug Administration granted Simplify Medical an investigational device exemption approval for their non-metal artificial disc.
Smith & Nephew earned a "hold" rating average from 21 firms covering the stock.
Jacob Rosenstein, MD, became the first surgeon in North America to perform an anterior cervical disc fusion with the Arena-C HA interbody with PEEK-OPTIMA HA Enhanced from SpineFrontier.
Stimwave Technologies announced plans to hire 20 new employees.
Synaptive Medical acquired intellectual property and products from ClearCanvas, a developer of imaging informatics solutions.
Zimmer announced the first reverse shoulder replacement in the United States using its Vivacit-E Liner for the Trabecular Metal Reverse Shoulder System.